Liraglutide vs Dulaglutide
Daily vs weekly GLP-1 dosing.
| Attribute | Liraglutide Saxenda, Victoza | Dulaglutide Trulicity |
|---|---|---|
| Category | Weight Loss & Metabolism | Weight Loss & Metabolism |
| Best known for | First-generation daily GLP-1 agonist research | Long-acting GLP-1 agonist research |
| In plain English | The original once-daily GLP-1; semaglutide is the once-weekly evolution. | Same idea as semaglutide — long-acting GLP-1 — with a different molecular backbone. |
| How it works | Activates GLP-1 receptors to enhance glucose-dependent insulin release, suppress glucagon, and slow gastric emptying. | Activates GLP-1 receptors to enhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying. |
| Researchers study | Type 2 diabetes, obesity, and cardiovascular outcomes. | Type 2 diabetes, cardiovascular risk reduction, and weight management. |
| Internet discussion | Discussed as 'first-gen Ozempic' on GLP-1 forums. | Discussed alongside semaglutide and tirzepatide on GLP-1 forums. |
Liraglutide
First-generation daily GLP-1 agonist research
The original once-daily GLP-1; semaglutide is the once-weekly evolution.
Activates GLP-1 receptors to enhance glucose-dependent insulin release, suppress glucagon, and slow gastric emptying.
Type 2 diabetes, obesity, and cardiovascular outcomes.
Discussed as 'first-gen Ozempic' on GLP-1 forums.
Liraglutide is a daily GLP-1 receptor agonist researched for glucose control and weight loss.
Dulaglutide
Long-acting GLP-1 agonist research
Same idea as semaglutide — long-acting GLP-1 — with a different molecular backbone.
Activates GLP-1 receptors to enhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying.
Type 2 diabetes, cardiovascular risk reduction, and weight management.
Discussed alongside semaglutide and tirzepatide on GLP-1 forums.
Dulaglutide is a long-acting GLP-1 receptor agonist researched for glucose control and weight management.